Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

219 Press Releases
DateTitleCompany
20 Apr 15 A New Hope for Asthma, COPD and Respiratory Diseases Patients! SOLIAIR™
14 Apr 15 Global Pharmacy Automation market to grow at a CAGR of 7.01% During 2015 Global Market News
14 Apr 15 Roche announces final results of tender offer for Foundation Medicine, Inc. Roche, Foundation Medicine,
Published by
PharmiWeb.com
14 Apr 15 Sanofi, Takeda, GSK and IAG Cargo to present at Europe’s Leading Clinical Trials Logistic 2015 Conference in London SMi Group Ltd
14 Apr 15 Hear Grunenthal’s latest screening approach for neuropathic pain and pain models SMi Group Ltd
14 Apr 15 Latest breakthrough on new pathways involved in the development of allergy to provide a better understanding of new targets for drug development and targeting SMi Group Ltd
13 Apr 15 SMi announce 10 reasons to attend BioBanking 2015 SMi Group Ltd
13 Apr 15 ellaOne® (ulipristal acetate) POM to P switch – new ‘P’ pack now available HRA Pharma UK
13 Apr 15 Microscopes Market Applications, Analysis, Trends And Segment Forecasts 2012 To 2020: Hexa Research Hexa Research
13 Apr 15 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis, Size, Application Analysis, Industry Outlook, Competitive Strategies And Forecasts, 2014 – 2020: Hexa Research Hexa Research
09 Apr 15 FURTHER WIRED HEALTH SPEAKERS ANNOUNCED PharmiWeb.com
08 Apr 15 PAREXEL Strengthens Commitment to Global Biopharmaceutical Workforce with New PAREXEL Academy Programs Parexel,
Published by
PharmiWeb.com
06 Apr 15 Innovative Pharmaceuticals, Biotechnology, Healthcare Leaders All Coming to Tokyo for Breakthrough Event Pharma CI Conference
01 Apr 15 Consortium signs deal with Basilea to develop resistance-busting cancer drugs Basilea, ICR,
Published by
PharmiWeb.com
31 Mar 15 Five of the World’s Top 20 Pharmaceutical Companies Standardize on Veeva Vault eTMF to Manage Clinical Trial Documents Globally Veeva,
Published by
PharmiWeb.com
31 Mar 15 Global Sodium Butazolidin Industry 2015 Market Survey Study Analysis and Overview QYResearchReports
30 Mar 15 CRO TO EXPAND GMP CAPABILITY PharmiWeb.com
30 Mar 15 Type 2 diabetes: CHMP recommends empagliflozin/metformin hydrochloride for approval in the European Union Boehringer Ingelheim and Lilly
30 Mar 15 Baxter Expands Access to Healthcare Through Collaborations and Charitable Giving Baxter,
Published by
PharmiWeb.com
30 Mar 15 Senior Director of Biomarkers at ImmunoGen Inc. to Speak at ADC Summit 2015 SMi Group Ltd
30 Mar 15 Teva Reinforces Leadership Position in CNS with Acquisition of Auspex Teva,
Published by
PharmiWeb.com
30 Mar 15 LEO Pharma A/S announces regulatory submission of ENSTILAR® for psoriasis in Europe LEO Pharma,
Published by
PharmiWeb.com
30 Mar 15 Vaxon Biotech appoints founder and chief scientific officer, Dr. Konstantinos Kosmatopoulos, as CEO Vaxon Biotech,
Published by
Andrew Lloyd and Associates
27 Mar 15 Parkinson's Life: a new 'webzine' for international Parkinson's community, launching April 2015 The European Parkinson's Disease Association
26 Mar 15 ABPI and BIA welcome the MMIP’s successful campaign to get funding for exciting new manufacturing design processes project ABPI,
Published by
PharmiWeb.com
26 Mar 15 PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership in Pharmacovigilance Services PAREXEL,
Published by
PharmiWeb.com
26 Mar 15 Lyophilized Injectables Growth at Fourteen Percent as Biologicals Proliferate Greystone Research Associates
26 Mar 15 Hear the latest breakthrough on Peptide Therapeutics being discussed at Peptides conference 2015 SMi Group Ltd
26 Mar 15 EISAI RECEIVES APPROVAL IN JAPAN FOR ANTICANCER AGENT LENVIMA® (LENVATINIB MESYLATE) AS TREATMENT FOR UNRESECTABLE THYROID CANCER EISAI,
Published by
PharmiWeb.com
26 Mar 15 Otsuka Granted Approval in Japan for a New Formulation of ABIILIFY – ABILIFY for Extended–release Injectable Suspension, for Intramuscular Use – Indicated for Schizophrenia Otsuka,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.